CLRO
ClearOne, Inc.
There isn't enough reported data to score CLRO yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
CLRO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
CLRO's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CLRO PE Valuation
CLRO has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CLRO Forward outlook
There aren't enough analyst estimates for CLRO to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CLRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.34 | +$10.07 |
| Q2 2026 | -$11.00 | -$4.16 |
| Q1 2026 | -$13.30 | -$7.30 |
| Q4 2025 | -$14.77 | -$9.22 |
| Q3 2025 | -$13.41 | -$10.71 |
| Q2 2025 | -$6.84 | -$4.59 |
| Q1 2025 | -$6.00 | -$4.95 |
| Q4 2024 | -$5.55 | -$5.25 |
CLRO lost $3.34 per share over the past year, a smaller loss than the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CLRO on earnings quality, reporting a profit while its opponent remains loss making.
CLRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.9M | -17% |
| Q1 2025 | $2.3M | -36% |
| Q4 2024 | $3M | -29% |
| Q3 2024 | $2.5M | -49% |
| Q2 2024 | $2.3M | -58% |
| Q1 2024 | $3.6M | -13% |
| Q4 2023 | $4.2M | +3.3% |
| Q3 2023 | $4.9M | -22% |
CLRO's revenue has slid since its 2020 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -238% | -111 points |
| Q1 2025 | -123% | -66 points |
| Q4 2024 | -68% | -27 points |
| Q3 2024 | -87% | -57 points |
| Q2 2024 | -127% | -102 points |
| Q1 2024 | -57% | -5 points |
| Q4 2023 | -42% | +23 points |
| Q3 2023 | -30% | -12 points |
CLRO's operating margin was −238% last quarter, down 111 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CLRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
CLRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$905K | +$224K |
| Q1 2026 | -$680K | +$776K |
| Q4 2025 | -$11.2M | -$9.7M |
| Q3 2025 | -$754K | +$1.1M |
| Q2 2025 | -$1.1M | +$2.1M |
| Q1 2025 | -$1.5M | -500% |
| Q4 2024 | -$1.6M | -145% |
| Q3 2024 | -$1.9M | -$50K |
CLRO has burned cash in most quarters: −$14M over the past year, against −$6M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CLRO on cash generation, producing positive trailing cash flow while its opponent burns cash.
CLRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +54% | +942K shares |
| 3 years | +68% | +1.1M shares |
| 5 years | +114% | +1.4M shares |
| Available history | +141% | +1.6M shares |
CLRO has 3M diluted shares, up 54% from a year ago.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CLRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CLRO Net Leverage
CLRO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CLRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 18.8 | Oversold |
CLRO's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CLRO PE vs Technology Sector
| Metric | CLRO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLRO has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CLRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.70 | 5.9% below |
| 20 week MA | $5.08 | 31% below |
| 50 week MA | $4.74 | 27% below |
| 100 week MA | $5.94 | 41% below |
| 200 week MA | $10.2 | 66% below |
CLRO is in a downtrend: it's below all five of its weekly moving averages, and 66% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over CLRO on trend strength, trading above more of its moving averages.
CLRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.3 | $37.2 | +42% |
| 2021 | $37.2 | $20.0 | -46% |
| 2022 | $20.0 | $23.1 | +16% |
| 2023 | $23.1 | $16.2 | -30% |
| 2024 | $16.2 | $9.13 | -44% |
| 2025 | $9.13 | $5.33 | -42% |
| 2026 YTD | $5.33 | $3.48 | -35% |
CLRO has finished three years in a row lower, and it's down 35% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CLRO on returns for 2026, with the stronger performance.